Biomarkers: CtDNA - Identifying cancer before it is clinically detectable

Nature Reviews Clinical Oncology

Volumn 12, Issue 7, 2015, Pages 372-

  Hutchinson, Lisa ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROPLAST DNA; IMMUNOGLOBULIN; DNA;

AMINO ACID SEQUENCE; CANCER EPIDEMIOLOGY; CANCER GROWTH; CANCER SCREENING; COMPUTER ASSISTED TOMOGRAPHY; DISEASE MARKER; DNA DETERMINATION; GENE REARRANGEMENT; HUMAN; INTERMETHOD COMPARISON; LARGE CELL LYMPHOMA; NEXT GENERATION SEQUENCING; NOTE; PRIORITY JOURNAL; FEMALE; GENETICS; HIGH THROUGHPUT SEQUENCING; MALE; RADIOGRAPHY;

DNA, NEOPLASM; FEMALE; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE;

EID: 84933279826     PISSN: 17594774     EISSN: 17594782     Source Type: Journal    
DOI: 10.1038/nrclinonc.2015.77     Document Type: Note

References (1)

1. Roschewski M., et al. Circulating tumour DNA and CT monitoring in patients with untreated diffuse large B-cell lymphoma: a correlative biomarker study. Lancet Oncol. doi:10.1016/S1470-2045(15)70106-3